Skip to main content
Caplight Logo









Eaglet Eye

Eaglet Eye

Private
HoutenHealthcare & Life Scienceshttps://www.eaglet-eye.com/

Last Round

Accelerator

Jan 8, 2024

Total Funding Raised

$326,000

Company Overview

Eaglet Eye is a medical device company that develops and commercializes high-tech ophthalmic imaging instruments, specifically the Eye Surface Profiler (ESP) for specialty contact lens fitting.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

corneo-scleral profilometerEye Surface ProfilerESPspecialty contact lensesscleral lens fittingorthokeratologyocular surface mappingfringe pattern analysis3D eye mappingmedical diagnostic devicecorneal topographyoptometry equipmentlens fitting softwareophthalmology toolseye care tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Eaglet Eye Comparables

Compare Eaglet Eye with similar companies based on industry and business-model similarity.

Eaglet Eye comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Euclid Vision Group
86%
Ovitz
78%
OCULUS Optikgeräte
78%

Eaglet Eye Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJan 8, 2024
CrowdfundingFeb 1, 2016

Key People

Founding team and executive leadership

Arnoud Snepvangers

Co-Founder, CEO

Founding Team

Eaglet Eye Investors

Notable investors and investment history

Eaglet Eye investors
InvestorRounds
HEC Paris Incubation and Acceleration CenterAccelerator
Zeeuws InvesteringsFondsCrowdfunding
Collin CrowdfundCrowdfunding
KIKK CapitalCrowdfunding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 21, 2026

    Grew 83% QoQ, from 6 to 11 employees.

  • Feb 24, 2025

    Monthly visitors increased 75% MoM.

Eaglet Eye Filings

Explore SEC and related filing metadata, where available.

Eaglet Eye filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Eaglet Eye's valuation, stock price, and market status.

Is Eaglet Eye a public or private company?

Eaglet Eye is a private company.

What is the current stock price of Eaglet Eye?

Eaglet Eye is a private company with no public stock price. No recent secondary market data is available.

How much is Eaglet Eye worth (valuation)?

Valuation information for Eaglet Eye is not publicly available.

Can I buy Eaglet Eye stock?

Eaglet Eye shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Eaglet Eye's last funding round?

Eaglet Eye's most recent funding round was Accelerator on January 8, 2024.

Who are the main investors in Eaglet Eye?

Key investors in Eaglet Eye include HEC Paris Incubation and Acceleration Center, Zeeuws InvesteringsFonds, Collin Crowdfund, KIKK Capital.

Will Eaglet Eye IPO soon?

No public IPO plans have been announced for Eaglet Eye.

How can I track Eaglet Eye secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Eaglet Eye's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHouten
Employee Range11
Year Founded2010
Last FundingJan 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?